San-tai Shen

Title: San-tai Shen: Innovator in Antibody Development

Introduction

San-tai Shen is a prominent inventor based in Miaoli County, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific receptors involved in vascular growth.

Latest Patents

One of his notable patents is for dual-function antibodies targeting VEGFR2 and VEGFR3. This patent describes an isolated antibody that comprises heavy chain complementary determining regions CDR1, CDR2, and CDR3 from a heavy chain variable region sequence having SEQ ID NO: 1 or 3. It also includes light chain complementary determining regions CDR1, CDR2, and CDR3 from a light chain variable region sequence having SEQ ID NO: 2 or 4. The antibody binds specifically to both vascular endothelial growth factor receptor-2 (VEGFR2) and vascular endothelial growth factor receptor-3 (VEGFR3). San-tai Shen holds 1 patent for this innovative work.

Career Highlights

San-tai Shen is affiliated with the National Health Research Institutes, where he conducts research and development in the field of health sciences. His work focuses on creating solutions that can potentially improve therapeutic outcomes for various medical conditions.

Collaborations

He has collaborated with notable colleagues, including Neng-Yao Shih and Ko-Jiunn Liu, to advance research in antibody development and its applications in medicine.

Conclusion

San-tai Shen's contributions to the field of biotechnology, particularly through his innovative patent on dual-function antibodies, highlight his role as a key inventor in advancing medical research. His work continues to pave the way for new therapeutic strategies.